LNPs were formulated as previously described4 (link),5 (link),27 (link), with the lipid components (SM-102, 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and PEG-2000 at molar ratios of 50:10:38.5:1.5) being rapidly mixed with an aqueous buffer solution containing ABE8.8 or SpRY-ABE8.8 mRNA and either PAH1 gRNA or PAH2 gRNA in a 1:1 ratio by weight in 25 mM sodium acetate (pH 4.0), with an N:P ratio of 5.6. The resulting LNP formulations were subsequently dialyzed against sucrose-containing buffer, concentrated using Amicon Ultra-15 mL Centrifugal Filter Units (Millipore Sigma), sterile-filtered using 0.2-μm filters, and frozen until use. The LNPs underwent quality control for particle size (Z-Ave, hydrodynamic diameter), polydispersity index as determined by dynamic light scattering (Malvern NanoZS Zetasizer) and total RNA encapsulation as measured by the Quant-iT Ribogreen Assay (Thermo Fisher Scientific).